Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Armillaria mellea, commonly known as honey mushroom, is recognized for its traditional use as an immune-modulating and anti-inflammatory agent. While preclinical studies support these properties, specific key bioactive compounds and their precise mechanisms of action are not well-documented in current research.
Reported Benefits (Provisional)
Origin & History
Armillaria mellea, commonly known as Honey Mushroom, is a group of medicinal fungi that grow in clusters on trees across temperate regions. These mushrooms are recognized for their immunomodulatory, anti-inflammatory, and anti-cancer properties. Traditionally used in Eastern medicine to enhance vitality, support immune function, and promote longevity, Armillaria mellea is rich in bioactive compounds like polysaccharides and terpenoids, offering numerous health benefits.
Research Narrative (Provisional)
A variety of preclinical and in vitro studies document the immune-modulating, anti-cancer, and anti-inflammatory properties of Armillaria mellea. This research supports its traditional use and growing popularity in modern wellness practices.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Polysaccharides: Including beta-glucans, key for immune modulation, anti-inflammatory, and anti-cancer effects, enhancing immune response and protecting against pathogens. - Terpenoids: Known for their antioxidant and anti-cancer properties. - Ergosterol: Important for immune modulation and as a precursor to vitamin D.
Reported Mechanism (Provisional)
While Armillaria mellea is traditionally associated with immune-modulating and anti-inflammatory effects, the specific molecular pathways, receptors, or bioactive compounds responsible for these actions are not explicitly detailed in the current research. Further investigation is needed to elucidate its precise mechanisms of action at a cellular or biochemical level.
Clinical Narrative (Provisional)
Current research on Armillaria mellea primarily consists of preclinical and in vitro studies, which have explored its immune-modulating, anti-cancer, and anti-inflammatory properties. These studies, typically conducted in laboratory settings or on animal models, support the mushroom's traditional uses but do not provide data from human clinical trials regarding efficacy, dosage, or specific health outcomes. Therefore, specific clinical results with sample sizes and measurable human outcomes are not available.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.